Phase 3 KEYNOTE-042 Study: Pembrolizumab vs Platinum-Based Chemotherapy as 1l Therapy for Advanced NSCLC with a PD-L1 TPS >= 1%


Creative Commons License

Lopes G., Wu Y., Kudaba I., Kowalski D., Cho B., Turna H., ...Daha Fazla

JOURNAL OF THORACIC ONCOLOGY, cilt.13, sa.9, 2018 (SCI-Expanded, Scopus)